Do data dilemmas impede digital health?
The launch of a proposal on the EU Health Data Space, expected in early May, forms the cornerstone of wider European ambitions on digital health, and marks the fruition of...
Category: Industry News
Real-World Data Show More Research is Needed for Risk Stratification in Advanced Colon Cancer
April 20, 2022 In an interview with Targeted Oncology, Luv Hajirawala, MD, discussed the relevance of high-risk features in patients with stage III colon cancer, and how a recent real-world...
Investigating FDA’s breakthrough devices, big data ethics, & AI for colon cancer
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and...
4 Pitfalls To Avoid With RWE For Regulatory Submissions
By Sean Hilscher, vice president, Greenleaf Health The FDA’s release of four draft guidances on real-world evidence (RWE) at the tail end of 2021 is a productive step toward implementing...
Help shape our evidence standards framework for digital and artificial intelligence health and care technologies
Harriet Unsworth outlines her role in updating our evidence standards framework for digital health technologies. She also explains how you can share your views as part of our consultation. 12...
Real-world evidence framework feedback
The NICE Strategy 2021 to 2026 states our ambition to use real-world data to resolve gaps in knowledge and drive forward access to innovations for patients. To help deliver on...
What’s Next for Real-World Evidence in Oncology?
April 13, 2022 Michael Vasconcelles, MD, Brad Jordan, PhD Evidence-Based Oncology, April 2022, Volume 28, Issue 3Pages: SP142-SP143 Recent steps by FDA to promote the use of real-world evidence are to be commended, but...
Real-World Analysis of THP in mBC Shows Similar Survival, Safety Outcomes to CLEOPATRA Trial
Pertuzumab combined with trastuzumab, and docetaxel revealed comparable survival outcomes with previous studies of patients with metastatic breast cancer, including the CLEOPATRA trial. A real-world analysis evaluating the triplet regimen...
Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients
ABSTRACT BACKGROUND: It is not known whether sotrovimab, a neutralizing monoclonal antibody (mAb) treatment authorized for early symptomatic COVID-19 patients, is effective against the SARS-CoV-2 Delta variant to prevent progression...
How to reduce racial disparities in cancer
Underrepresentation of racial minorities in clinical trials for cancer and other diseases isn’t new; there has been a significant dearth in the representation of minorities in oncology trials for years....